Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Investigational lipid eye drops are a lipid-based lubricating formulation developed by Johnson & Johnson Vision Care, Inc. for the management of dry eye syndrome, particularly in individuals who wear contact lenses. These drops are designed to mimic and supplement the natural lipid layer of the tear film, which is essential for preventing the evaporation of tears and maintaining ocular surface stability. In clinical evaluations, such as the Phase 1 study NCT04181437, the formulation was tested to ensure that the addition of lipids does not adversely affect visual acuity in soft contact lens wearers while providing lubrication compared to non-lipid-based drops like Blink Tears.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Investigational lipid eye drops.